Detalhe da pesquisa
1.
Non-pegylated liposomal doxorubicin in older adjuvant early breast cancer patients: cardiac safety analysis and final results of the COLTONE study.
Clin Exp Med
; 23(8): 5113-5120, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37634231
2.
A pharmacogenetic interaction analysis of bevacizumab with paclitaxel in advanced breast cancer patients.
NPJ Breast Cancer
; 8(1): 33, 2022 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35314692
3.
Cardiac safety of adjuvant non-pegylated liposomal doxorubicin combined with cyclophosphamide and followed by paclitaxel in older breast cancer patients.
Breast
; 31: 186-191, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27886643
4.
Pharmacogenetic interaction analysis of VEGFR-2 and IL-8 polymorphisms in advanced breast cancer patients treated with paclitaxel and bevacizumab.
Pharmacogenomics
; 15(16): 1985-99, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25521357